| |
Preschools see sharp drop in funding: study Monday, Apr 29, 2013 11:28 AM PDT | Top |
South Africa's Mandela frail in first TV footage in months Monday, Apr 29, 2013 11:23 AM PDT | Top |
Merck, Pfizer to jointly develop diabetes drug Monday, Apr 29, 2013 11:20 AM PDT | Top |
Five convicted in Kosovo organ trafficking case Monday, Apr 29, 2013 10:38 AM PDT | Top |
Mother forced daughter, 14, into sperm insemination - UK court Monday, Apr 29, 2013 09:27 AM PDT By Estelle Shirbon LONDON (Reuters) - A mother who persuaded her adopted teenage daughter to become pregnant by artificial insemination because she wanted a baby for herself has been jailed for five years in Britain, in a case that raises concern over how easily donor sperm can be obtained. Previously secret court documents showed that the daughter, a virgin, was made to inseminate herself alone in her bedroom seven times over a two-year period starting in 2008 when she was 14, using syringes of semen bought online by the mother from sperm bank Cryos in Denmark. ... Full Story | Top |
Auxilium cuts sales view on drugs, expands urology business Monday, Apr 29, 2013 09:21 AM PDT (Reuters) - Auxilium Pharmaceuticals Inc reported a big fall in quarterly sales in the United States for both its drugs, and said it acquired Actient Holdings LLC to bolster its urology business. Shares of Auxilium fell as much as 13.5 percent to $13.87 — their lowest in a year-and-a-half — on the Nasdaq on Monday. Revenue fell 10 percent in the first quarter to $66.2 million, below analysts' average estimate of $81.23 million, according to Thomson Reuters I/B/E/S. Testosterone gel Testim's sales, almost all of which come from the United States, fell 23 percent to $45.5 million. ... Full Story | Top |
Tabata metes out fitness in short, repeated flashes Monday, Apr 29, 2013 07:27 AM PDT | Top |
China reports latest bird flu death Monday, Apr 29, 2013 06:48 AM PDT | Top |
South Africa's Mandela in good health, good spirits: ANC Monday, Apr 29, 2013 06:45 AM PDT | Top |
FDA rejects two Gilead HIV drugs as standalone products Monday, Apr 29, 2013 06:35 AM PDT By Toni Clarke WASHINGTON (Reuters) - Gilead Sciences Inc said on Monday that U.S. health rejected two of its HIV drugs as standalone therapies, citing deficiencies in documentation and validation of certain quality testing procedures. Gilead said it is working with U.S. Food and Drug Administration to address the questions raised in the rejection letter in order to prove the application forward. The company is seeking approval for its drug elvitegravir for people with HIV, the virus that causes AIDS, who have already been treated with other products. ... Full Story | Top |
Impax, GSK end Parkinson's disease partnership Monday, Apr 29, 2013 06:07 AM PDT (Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK has rights to market the drug. Impax shares fell 2 percent to $17.32 in premarket trade after closing at $17.62 on Friday on the Nasdaq. Under a deal, GlaxoSmithKline had the right to develop and market the drug, IPX066, outside the United States and Taiwan. Rights to the drug, which is known as Rytary in the United States, will transfer back to Impax at the end of July 2013. ... Full Story | Top |
EU drugs agency recommends suspension of tetrazepam Monday, Apr 29, 2013 04:27 AM PDT LONDON (Reuters) - EU drugs regulators have recommended suspending use of all tetrazepam-containing medicines following reports of serious skin reactions, the European Medicines Agency said on Monday. Tetrazepam belong to a class of drugs known as benzodiazepines and is used in several European Union countries to treat conditions such as back and neck pain and spasticity. (Reporting by Kate Kelland, editing by Ben Hirschler) Full Story | Top |
Bayer to buy birth-control devices maker for $1.1 billion Monday, Apr 29, 2013 03:48 AM PDT | Top |
Respect women's choice to have home birth: doctors Sunday, Apr 28, 2013 09:09 PM PDT | Top |
In abortion debate, both sides point to Philadelphia trial Sunday, Apr 28, 2013 09:04 PM PDT Full Story | Top |
|
No comments:
Post a Comment